Skip to main content
Tweets by IDWeek 2021
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
David A. Angulo, MD
Chief Medical Officer
Outcomes of Candida Bone and Joint Infections in Eight Patients from a Phase 3 Open-label Study (FURI)
Oral Ibrexafungerp Outcomes in Patients with Oropharyngeal and Esophageal Candidiasis from an Interim Analysis of a Phase 3 Open-label Study (FURI)